Search research articles
Contact Us
Filters
Showing results (61-70 of 748) with videos related to
Page
of 75
Sort By:
Anti-Cancer Drug Design
|
May 1, 1990
Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity
W A Denny, L P Wakelin
Journal of Medicinal Chemistry
|
June 1, 1986
Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells
W A Denny, W R Wilson
Journal of Medicinal Chemistry
|
April 1, 1977
Potential antitumor agents. 21. Dialkanolamine dialkanesulfonic esters
B F Cain, W A Denny
Expert Opinion on Therapeutic Patents
|
October 28, 2020
Small-molecule CSF1R kinase inhibitors; review of patents 2015-present
William A Denny, Jack U Flanagan
The Journal of Nursing Education
|
January 1, 1979
A comparison of mental health nursing education in the United Kingdom and the psychiatric component of a baccalaureate program in the United States
E O Denny, J A Denny
Future Medicinal Chemistry
|
March 24, 2011
The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies
William A Denny, Brian D Palmer
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
September 10, 2005
Human papillomavirus testing and screening
L A Denny, T C Wright
The Anatomical Record
|
March 30, 1999
Dynamics of parenchymal cell division, differentiation, and apoptosis in the young adult female mouse submandibular gland
P C Denny, P A Denny
Expert Opinion on Investigational Drugs
|
November 28, 2000
Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia
W A Denny, W R Wilson
Mutation Research
|
September 1, 1995
Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?
L R Ferguson, W A Denny
Page
of 75
Search research articles
Search
Showing results (61-70 of 748) with videos related to
Sort By:
Page
of 75
Anti-Cancer Drug Design
|
May 1, 1990
Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity
W A Denny, L P Wakelin
Journal of Medicinal Chemistry
|
June 1, 1986
Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells
W A Denny, W R Wilson
Journal of Medicinal Chemistry
|
April 1, 1977
Potential antitumor agents. 21. Dialkanolamine dialkanesulfonic esters
B F Cain, W A Denny
Expert Opinion on Therapeutic Patents
|
October 28, 2020
Small-molecule CSF1R kinase inhibitors; review of patents 2015-present
William A Denny, Jack U Flanagan
The Journal of Nursing Education
|
January 1, 1979
A comparison of mental health nursing education in the United Kingdom and the psychiatric component of a baccalaureate program in the United States
E O Denny, J A Denny
Future Medicinal Chemistry
|
March 24, 2011
The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies
William A Denny, Brian D Palmer
Best Practice & Research. Clinical Obstetrics & Gynaecology
|
September 10, 2005
Human papillomavirus testing and screening
L A Denny, T C Wright
The Anatomical Record
|
March 30, 1999
Dynamics of parenchymal cell division, differentiation, and apoptosis in the young adult female mouse submandibular gland
P C Denny, P A Denny
Expert Opinion on Investigational Drugs
|
November 28, 2000
Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia
W A Denny, W R Wilson
Mutation Research
|
September 1, 1995
Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?
L R Ferguson, W A Denny
Page
of 75